MREO
Mereo BioPharma Group plc
+0.01 (+3.38%)0.28USD431K成交股數–市值–本益比(近四季)–股價營收比-100.0%營收年增(近四季)2026-11-09下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 0.00 |
| 近 180 天 淨額 | 0.00 |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2024-09-13 | 09-16 | Hughes-Wilson Alexandra | See Remarks | S 公開市場賣出 | 16.3K | 4.22 | 69K | 134K | SEC |
| 2024-09-13 | 09-16 | Sermon Charles | General Counsel | S 公開市場賣出 | 20.9K | 4.22 | 88K | 219K | SEC |
| 2024-09-13 | 09-16 | Fox Christine Ann | Chief Financial Officer | S 公開市場賣出 | 19.2K | 4.22 | 81K | 89.3K | SEC |
| 2024-09-13 | 09-16 | Lewicki John A. | Chief Scientific Officer | S 公開市場賣出 | 10.9K | 4.22 | 46K | 78.6K | SEC |
| 2024-09-13 | 09-16 | Hughes-Wilson Alexandra | See Remarks | S 公開市場賣出 | 84.0K | 4.22 | 355K | 50.5K | SEC |
| 2024-09-13 | 09-16 | Scots-Knight Denise | Chief Executive Officer | S 公開市場賣出 | 60.0K | 4.22 | 253K | 809K | SEC |
| 2024-09-12 | 09-16 | Hughes-Wilson Alexandra | See Remarks | S 公開市場賣出 | 40.0K | 4.47 | 179K | 151K | SEC |
| 2024-09-12 | 09-16 | Fox Christine Ann | Chief Financial Officer | S 公開市場賣出 | 9.1K | 4.47 | 41K | 108K | SEC |
| 2024-09-12 | 09-16 | Hughes-Wilson Alexandra | See Remarks | S 公開市場賣出 | 7.8K | 4.47 | 35K | 191K | SEC |
| 2024-09-12 | 09-16 | Sermon Charles | General Counsel | S 公開市場賣出 | 10.0K | 4.47 | 45K | 240K | SEC |
| 2024-09-12 | 09-16 | Lewicki John A. | Chief Scientific Officer | S 公開市場賣出 | 5.2K | 4.47 | 23K | 89.6K | SEC |
| 2024-09-12 | 09-16 | Scots-Knight Denise | Chief Executive Officer | S 公開市場賣出 | 28.6K | 4.47 | 128K | 869K | SEC |
| 2024-09-11 | 09-13 | Hughes-Wilson Alexandra | See Remarks | M 選擇權執行 | 40.0K | – | – | 74.5K | SEC |
| 2024-09-11 | 09-13 | Hughes-Wilson Alexandra | See Remarks | M 選擇權執行 | 93.3K | 1.40 | 131K | 168K | SEC |
| 2024-09-11 | 09-13 | Hughes-Wilson Alexandra | See Remarks | M 選擇權執行 | 75.0K | 1.01 | 76K | 243K | SEC |
| 2024-09-11 | 09-13 | Scots-Knight Denise | Chief Executive Officer | M 選擇權執行 | 188K | – | – | 898K | SEC |
| 2024-09-11 | 09-13 | Lewicki John A. | Chief Scientific Officer | M 選擇權執行 | 46.0K | – | – | 94.8K | SEC |
| 2024-09-11 | 09-13 | Fox Christine Ann | Chief Financial Officer | M 選擇權執行 | 60.0K | – | – | 118K | SEC |
| 2024-09-11 | 09-13 | Sermon Charles | General Counsel | M 選擇權執行 | 65.6K | – | – | 250K | SEC |
| 2024-08-22 | 08-23 | PAKIANATHAN DEEPIKA | Director | M 選擇權執行 | 2.1K | 3.87 | 8K | 105K | SEC |
| 2024-08-22 | 08-23 | PAKIANATHAN DEEPIKA | Director | M 選擇權執行 | 1.8K | 3.00 | 5K | 1.8K | SEC |
| 2024-08-22 | 08-23 | PAKIANATHAN DEEPIKA | Director | M 選擇權執行 | 6.5K | 1.84 | 12K | 8.3K | SEC |
| 2024-08-22 | 08-23 | PAKIANATHAN DEEPIKA | Director | M 選擇權執行 | 12.4K | 2.72 | 34K | 20.7K | SEC |
| 2024-08-22 | 08-23 | PAKIANATHAN DEEPIKA | Director | M 選擇權執行 | 39.0K | 1.31 | 51K | 59.7K | SEC |
| 2024-08-22 | 08-23 | PAKIANATHAN DEEPIKA | Director | M 選擇權執行 | 43.5K | 0.94 | 41K | 103K | SEC |
| 2024-08-22 | 08-23 | PAKIANATHAN DEEPIKA | Director | S 公開市場賣出 | 105K | 4.43 | 466K | 0 | SEC |
| 2024-06-26 | 06-27 | Sermon Charles | General Counsel | S 公開市場賣出 | 32.2K | 3.39 | 109K | 184K | SEC |
| 2024-06-26 | 06-27 | Scots-Knight Denise | Chief Executive Officer | S 公開市場賣出 | 92.3K | 3.39 | 313K | 710K | SEC |
| 2024-06-26 | 06-27 | Fox Christine Ann | Chief Financial Officer | S 公開市場賣出 | 29.4K | 3.39 | 100K | 57.6K | SEC |
| 2024-06-26 | 06-27 | Lewicki John A. | Chief Scientific Officer | S 公開市場賣出 | 16.8K | 3.39 | 57K | 48.8K | SEC |
| 2024-06-26 | 06-27 | Hughes-Wilson Alexandra | See Remarks | S 公開市場賣出 | 23.0K | 3.39 | 78K | 34.5K | SEC |
| 2024-06-25 | 06-27 | Sermon Charles | General Counsel | S 公開市場賣出 | 14.2K | 3.69 | 52K | 217K | SEC |
| 2024-06-25 | 06-27 | Hughes-Wilson Alexandra | See Remarks | S 公開市場賣出 | 10.1K | 3.69 | 37K | 57.5K | SEC |
| 2024-06-25 | 06-27 | Scots-Knight Denise | Chief Executive Officer | S 公開市場賣出 | 40.7K | 3.69 | 150K | 802K | SEC |
| 2024-06-25 | 06-27 | Lewicki John A. | Chief Scientific Officer | S 公開市場賣出 | 7.4K | 3.69 | 27K | 65.6K | SEC |
| 2024-06-25 | 06-27 | Fox Christine Ann | Chief Financial Officer | S 公開市場賣出 | 13.0K | 3.69 | 48K | 87.0K | SEC |
| 2024-06-21 | 06-25 | Fox Christine Ann | Chief Financial Officer | M 選擇權執行 | 90.0K | – | – | 100K | SEC |
| 2024-06-21 | 06-25 | Hughes-Wilson Alexandra | See Remarks | M 選擇權執行 | 60.0K | – | – | 67.7K | SEC |
| 2024-06-21 | 06-25 | Sermon Charles | General Counsel | M 選擇權執行 | 98.4K | – | – | 231K | SEC |
| 2024-06-21 | 06-25 | Scots-Knight Denise | Chief Executive Officer | M 選擇權執行 | 282K | – | – | 843K | SEC |
| 2024-06-21 | 06-25 | Lewicki John A. | Chief Scientific Officer | M 選擇權執行 | 69.0K | – | – | 73.0K | SEC |
| 2024-06-17 | 06-17 | Bender Jeremy | Director | A 獲配股票 | 12.6K | 3.99 | 50K | 12.6K | SEC |
| 2024-06-17 | 06-17 | WYZGA MICHAEL S | Director | A 獲配股票 | 25.1K | 3.99 | 100K | 25.1K | SEC |
| 2024-05-22 | 05-23 | Hughes-Wilson Alexandra | See Remarks | M 選擇權執行 | 93.3K | 1.40 | 131K | 101K | SEC |
| 2024-05-22 | 05-23 | Hughes-Wilson Alexandra | See Remarks | S 公開市場賣出 | 50.4K | 2.99 | 151K | 58.6K | SEC |
| 2024-05-22 | 05-23 | Hughes-Wilson Alexandra | See Remarks | F 繳稅扣股 | 43.0K | 1.40 | 60K | 7.7K | SEC |
| 2024-05-22 | 05-23 | Hughes-Wilson Alexandra | See Remarks | M 選擇權執行 | 75.0K | 1.01 | 76K | 82.7K | SEC |
| 2024-05-22 | 05-23 | Hughes-Wilson Alexandra | See Remarks | S 公開市場賣出 | 50.1K | 2.94 | 147K | 32.6K | SEC |
| 2024-05-22 | 05-23 | Hughes-Wilson Alexandra | See Remarks | F 繳稅扣股 | 24.9K | 1.01 | 25K | 7.7K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| Rubric Capital Management LP | 15.3M | 4.9M | 新進 | 新進 |
| 683 Capital Management, LLC | 11.8M | 3.7M | 新進 | 新進 |
| BANK OF AMERICA CORP /DE/ | 8.2M | 2.6M | 新進 | 新進 |
| Defilade Capital Management, L.P. | 7.6M | 2.4M | 新進 | 新進 |
| Newtyn Management, LLC | 3.0M | 953K | 新進 | 新進 |
| Tejara Capital Ltd | 2.0M | 647K | 新進 | 新進 |
| UBS Group AG | 1.4M | 460K | 新進 | 新進 |
| Two Sigma TWO SIGMA INVESTMENTS, LP | 1.3M | 419K | 新進 | 新進 |
| EcoR1 Capital, LLC | 1.0M | 318K | 新進 | 新進 |
| JANE STREET GROUP, LLC | 775K | 246K | 新進 | 新進 |
| Ishara Investments LP | 769K | 244K | 新進 | 新進 |
| Wealthspire Advisors, LLC | 765K | 243K | 新進 | 新進 |
| 城堡 CITADEL ADVISORS LLC | 444K | 141K | 新進 | 新進 |
| Rangeley Capital, LLC | 329K | 105K | 新進 | 新進 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 213K | 68K | 新進 | 新進 |
| MARSHALL WACE, LLP | 180K | 58K | 新進 | 新進 |
| XTX Topco Ltd | 174K | 55K | 新進 | 新進 |
| GROUP ONE TRADING LLC | 168K | 53K | 新進 | 新進 |
| STATE STREET CORP | 135K | 43K | 新進 | 新進 |
| NOMURA HOLDINGS INC | 104K | 33K | 新進 | 新進 |
| James J. Burns & Company, LLC | 95.4K | 30K | 新進 | 新進 |
| Quarry LP | 93.8K | 30K | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 85.2K | 27K | 新進 | 新進 |
| JMN Financial LLC | 76.7K | 24K | 新進 | 新進 |
| BlackRock, Inc. | 69.7K | 22K | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 61 -2 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 61 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 56.6M |
| 合計季末市值 | 18.0M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 3.8M |
|---|---|
| 與上期比 | -12.8% |
| 佔流通股數 | –(外國發行人不算) |
| 日均成交量 | 1.1M |
| 回補天數 | 3.4 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 3.8M | -12.8% | – | 1.1M | 3.4 |
| 2026-08-14 | 4.3M | +26.4% | – | 17.7M | 1.0 |
| 2026-07-31 | 3.4M | -3.5% | – | 1.0M | 3.4 |
| 2026-07-15 | 3.5M | -39.9% | – | 1.1M | 3.2 |
| 2026-06-30 | 5.9M | +10.0% | – | 1.9M | 3.2 |
| 2026-06-15 | 5.3M | -34.5% | – | 3.4M | 1.6 |
| 2026-05-29 | 8.2M | +43.6% | – | 11.1M | 1.0 |
| 2026-05-15 | 5.7M | -12.7% | – | 1.8M | 3.1 |
| 2026-04-30 | 6.5M | -21.3% | – | 1.5M | 4.4 |
| 2026-04-15 | 8.3M | -24.2% | – | 1.7M | 4.8 |
| 2026-03-31 | 10.9M | -3.1% | – | 1.4M | 7.7 |
| 2026-03-13 | 11.3M | -18.2% | – | 1.4M | 7.9 |
| 2026-02-27 | 13.8M | -2.3% | – | 2.6M | 5.4 |
| 2026-02-13 | 14.1M | +8.1% | – | 3.6M | 3.9 |
| 2026-01-30 | 13.0M | +32.9% | – | 8.7M | 1.5 |
| 2026-01-15 | 9.8M | -6.7% | – | 36.0M | 1.0 |
| 2025-12-31 | 10.5M | +7.5% | – | 34.3M | 1.0 |
| 2025-12-15 | 9.8M | +6.3% | – | 2.9M | 3.4 |
| 2025-11-28 | 9.2M | -0.5% | – | 1.3M | 7.2 |
| 2025-11-14 | 9.2M | -8.6% | – | 1.4M | 6.4 |
| 2025-10-31 | 10.1M | -9.3% | – | 1.7M | 6.1 |
| 2025-10-15 | 11.2M | -3.5% | – | 1.5M | 7.6 |
| 2025-09-30 | 11.6M | +4.7% | – | 1.1M | 10.7 |
| 2025-09-15 | 11.0M | -2.2% | – | 1.0M | 11.0 |
| 2025-08-29 | 11.3M | +7.6% | – | 891K | 12.7 |
| 2025-08-15 | 10.5M | -0.6% | – | 1.6M | 6.5 |